Race and Disparities in Health

Current Problems in Cancer

Volumn 31, Issue 3, 2007, Pages 114-122

  Brawley, Otis W ^a   Jani, Ashesh B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; COLORECTAL CANCER; ETHNICITY; HEMATOLOGIC DISEASE; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; RACE DIFFERENCE; UTERINE CERVIX CANCER;

CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; MALE; NEOPLASMS; RISK FACTORS; SCOTLAND; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 34249685599     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2007.02.001     Document Type: Article

References (24)

1. Henschke U.K., Leffall Jr. L.D., Mason C.H., Reinhold A.W., Schneider R.L., and White J.E. Alarming increase of the cancer mortality in the U.S. black population (1950-1967). Cancer 31 (1973) 763-768
2. Reis LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2002.
3. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring. J Natl Cancer Inst 97 (2005) 1407-1427
4. Goldson A., Henschke U., Leffall L.D., and Schneider R.L. Is there a genetic basis for the differences in cancer incidence between Afro-Americans and Euro-Americans?. J Natl Med Assoc 73 (1981) 701-706
5. Amling C.L., Riffenburgh R.H., Sun L., Moul J.W., Lance R.S., Kusada L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
6. Tarman G.J., Kane C.J., Moul J.W., Thrasher J.B., Foley J.P., Wilhite D., et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56 (2000) 1016-1020
7. Harlan L.C., Coates R.J., Block G., Greenberg R.S., Ershow A., Forman M., et al. Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiology 4 (1993) 25-31
8. Thomson C.S., Hole D.J., Twelves C.J., Brewster D.H., and Black R.J. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health 55 (2001) 308-315
9. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2002.
10. Brawley O.W. Some perspective on black-white cancer statistics. CA Cancer J Clin 52 (2002) 322-325
11. Brawley O.W. Population categorization and cancer statistics. Cancer Metastasis Rev 22 (2003) 11-19
12. Haenszel W., and Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40 (1968) 43-68
13. Satia-Abouta J., Patterson R.E., Neuhouser M.L., and Elder J. Dietary acculturation: applications to nutrition research and dietetics. J Am Diet Assoc 102 (2002) 1105-1118
14. Ward E., Jemal A., Cokkinides V., Singh G.K., Cardinez C., Ghafoor A., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54 2 (2004) 78-93
15. Gordon N.H. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142 (1995) 796-803
16. Gordon N.H. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22 (2003) 55-65
17. NIH Revitalization Act of 1993: Public law 103-43, June 10, 1993. 2004.
18. Freedman L.S., Simon R., Foulkes M.A., Friedman L., Geller N.L., Gordon D.J., et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993: the perspective of NIH clinical trialists. Control Clin Trials 16 (1995) 277-285
19. Gupta E., Mick R., Ramirez J., Wang X., Lestingi T.M., Vokes E.E., et al. Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients. J Clin Oncol 15 (1997) 1502-1510
20. Shavers V.L., and Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94 (2002) 334-357
21. Bach P.B., Schrag D., Brawley O.W., Galaznik A., Yakren S., and Begg C.B. Survival of blacks and whites after a cancer diagnosis. J Am Med Assoc 287 (2002) 2106-2113
22. Swan J., Breen N., Coates R.J., Rimer B.K., and Lee N.C. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97 (2003) 1528-1540
23. Brown V. Board of Education of Topeka, 347 U.S. Supreme Court 483 (1954).
24. Bach P.B., Pham H.H., Schrag D., Tate R.C., and Hargraves J.L. Primary care physicians who treat blacks and whites. N Engl J Med 351 (2004) 575-584